Publications by authors named "Martin D Forster"

Claim this Profile
I
International, Multi-Institutional Evaluation of Practice Patterns and Outcomes for Recurrent and Metastatic Sinonasal Undifferentiated Carcinoma.
Anirudh Saraswathula, Mohammed N Ullah, Jacklyn Liu, Yoko Takahashi, Arushi Mahajan, Martin D Forster

J Neurol Surg B Skull Base· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial.
Magnus T Dillon, Emmanuel C Patin, Kabir Mohammed, Jeane Guevara, Simon A Smith, Martin D Forster

Nat Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials for patients with salivary gland cancers: A systematic review of worldwide registers and an evaluation of current challenges.
Pablo Jiménez-Labaig, Luigi Lorini, Cristina Gurizzan, Emma Kinloch, Sarah Burton, Martin D Forster

Crit Rev Oncol Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements.
Seshiru Nakazawa, Federica Pecci, Igor Odintsov, Dimitris Gazgalis, Felix H Gottlieb, Martin D Forster

Cancer Discov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.
Maise Al Bakir, James L Reading, Samuel Gamble, Rachel Rosenthal, Imran Uddin, Martin D Forster

Nature· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expression.
Jacklyn Liu, Helen Bewicke-Copley, Shruti Patel, Oscar Emanuel, Nicholas Counsell, Martin D Forster

Clin Transl Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of heart failure medical therapy before and after a cancer diagnosis: A longitudinal study.
Chengsheng Ju, Wallis C Y Lau, Charlotte Manisty, Pinkie Chambers, Ruth Brauer, Martin D Forster

ESC Heart Fail· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancer.
Searan Karamchandani, Axel Sahovaler, Elizabeth Crosbie-Jones, Mark McGurk, Selvam Thavaraj, Martin D Forster

Oral Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer.
Luke Steventon, Kenneth K C Man, Shibani Nicum, Rowan E Miller, Shira Peleg Hasson, Martin D Forster

Oncologist· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective cohort study.
Luke Steventon, Emma Kipps, Kenneth Kc Man, Rebecca Roylance, Martin D Forster

Eur J Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation.
David M Waterhouse, Sacha Rothschild, Christophe Dooms, Bertrand Mennecier, Farastuk Bozorgmehr, Martin D Forster

Lung Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx.
Alexander M Frankell, Michelle Dietzen, Maise Al Bakir, Emilia L Lim, Takahiro Karasaki, Martin D Forster

Nature· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of statin treatment on the risk of cancer in patients with heart failure: A target trial emulation study.
Chengsheng Ju, Wallis C Y Lau, Pinkie Chambers, Kenneth K C Man, Martin D Forster

Pharmacoepidemiol Drug Saf· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors.
Filip Janku, Grace M Choong, Mateusz Opyrchal, Afshin Dowlati, Cinta Hierro, Martin D Forster

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation.
Magnus T Dillon, Jeane Guevara, Kabir Mohammed, Emmanuel C Patin, Simon A Smith, Martin D Forster

J Clin Invest· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancer.
Anthony Kong, Amanda J Kirkham, Joshua S Savage, Rhys Mant, Siân Lax, Martin D Forster

BJC Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer.
Melinda A Pruis, Matthew G Krebs, Ruth Plummer, Filip De Vos, Eric Angevin, Martin D Forster

Oncologist· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalising monitoring for chemotherapy patients through predicting deterioration in renal and hepatic function.
Pinkie Chambers, Matthew Watson, John Bridgewater, Martin D Forster, Rebecca Roylance

Cancer Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System.
Matt Lechner, Yoko Takahashi, Mario Turri-Zanoni, Marco Ferrari, Jacklyn Liu, Martin D Forster

J Neurol Surg B Skull Base· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a G12C Mutation.
Adrian Sacher, Patricia LoRusso, Manish R Patel, Wilson H Miller, Elena Garralda, Martin D Forster

N Engl J Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution of non-small cell lung cancer metastases in TRACERx.
Maise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, Kristiana Grigoriadis, Thomas B K Watkins, Martin D Forster

Nature· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution of lung cancer and impact of subclonal selection in TRACERx.
Alexander M Frankell, Michelle Dietzen, Maise Al Bakir, Emilia L Lim, Takahiro Karasaki, Martin D Forster

Nature· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative burden of 144 conditions, critical care hospitalisation and premature mortality across 26 adult cancers.
Wai Hoong Chang, Richard D Neal, Martin D Forster, Alvina G Lai

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphenotypic sinonasal sarcoma: European multicentre case-series and systematic literature review.
Mario Turri-Zanoni, Gianluca Dalfino, Matt Lechner, Iacopo Dallan, Paolo Battaglia, Martin D Forster

Acta Otorhinolaryngol Ital· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.
Matt Lechner, Yoko Takahashi, Mario Turri-Zanoni, Jacklyn Liu, Nicholas Counsell, Martin D Forster

Eur J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis